Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Adma Biologics Inc (NASDAQ: ADMA) closed the day trading at $16.71 up 2.39% from the previous closing price of $16.32. In other words, the price has increased by $2.39 from its previous closing price. On the day, 2.73 million shares were traded. ADMA stock price reached its highest trading level at $17.3199 during the session, while it also had its lowest trading level at $16.48.
Ratios:
For a better understanding of ADMA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 45.56 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 49.76. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 7.09. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 22 ’24 when Tade Brad L. sold 15,000 shares for $21.15 per share. The transaction valued at 317,250 led to the insider holds 199,433 shares of the business.
Grossman Adam S sold 48,967 shares of ADMA for $1,033,204 on Nov 22 ’24. The President and CEO now owns 1,989,007 shares after completing the transaction at $21.10 per share. On Nov 22 ’24, another insider, Grossman Adam S, who serves as the Director and Officer of the company, bought 48,967 shares for $21.30 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 3950076672 and an Enterprise Value of 3974758144. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 60.48, and their Forward P/E ratio for the next fiscal year is 24.45. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.88. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.32 while its Price-to-Book (P/B) ratio in mrq is 17.03. Its current Enterprise Value per Revenue stands at 10.383 whereas that against EBITDA is 31.572.
Stock Price History:
The Beta on a monthly basis for ADMA is 0.76, which has changed by 2.250996 over the last 52 weeks, in comparison to a change of 0.22212577 over the same period for the S&P500. Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $4.82. The 50-Day Moving Average of the stock is -13.29%, while the 200-Day Moving Average is calculated to be 15.71%.
Shares Statistics:
Over the past 3-months, ADMA traded about 3.06M shares per day on average, while over the past 10 days, ADMA traded about 2354580 shares per day. A total of 236.38M shares are outstanding, with a floating share count of 228.50M. Insiders hold about 3.34% of the company’s shares, while institutions hold 87.24% stake in the company. Shares short for ADMA as of 1735603200 were 13622817 with a Short Ratio of 4.46, compared to 1732838400 on 12906077. Therefore, it implies a Short% of Shares Outstanding of 13622817 and a Short% of Float of 5.9299998.
